Glucagon-like Peptide-1 (GLP-1) and Protective Effects in Cardiovascular Disease: A New Therapeutic Approach for Myocardial Protection
Statistical analysis All statistical tests were carried out using GraphPad Prism software, version 8 (GraphPad Software, Inc., USA)
There are a lot of good podcasts available through them
It does not cure obesity or diabetes, but it helps manage them
With tesamorelin, the most likely adverse events, according to the clinicians we know, are mild flu-like symptoms such as fatigue, headache, and nausea, but its also associated with an increased risk of cancer owing to its activity on growth hormone5 certainly more worrisome than the gastrointestinal problems linked to GLP-1 RAs
The following input was provided by 1 clinical specialist with expertise in the diagnosis and management of T2DM